As many of us have been posting for awhile now, there's exciting things happening at Immunomedics that we already know about, and clearly some major excitement in immu's clinical activity.
As we've seen with other stocks like Immu, like ZYNE and GW Gharma, e.g., these cannabis clinical stocks can be and are explposive on the upside big time on any given day.
Developing medical safety and efficacy, is where the very exciting growth and dramatic price appreciation will exist (in the clinical/research sector and in Testing sector, like with Signal Bay, SGBY).
Something clinically/research wise positive is happening, imo. THe company's already alluded to this.
Couple this dimension, with the developing exciting German/European acquisition and expansion underway, and IMMU represents one exciting and potentially very profitable investment and at sale prices.
Smart move for those doing their homework and seeing what's sarty investing wise developing. GLTY.